Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Calvo PA"" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł:
A feminine subject in postmodernist chaos: Janette Winterson's political manifesto in Oranges are not the only fruit
Autorzy:
Calvo Pascual, Mónica
Pokaż więcej
Temat:
English language
PE1-3729
English literature
PR1-9680
Źródło:
Revista Alicantina de Estudios Ingleses, Iss 13, p 21 (2000)
Opis pliku:
electronic resource
Relacje:
https://raei.ua.es/article/view/2000-n13-a-feminine-subject-in-postmodernist-chaos-janette-wintersons-political-manifesto-in-oranges-are-not-the-only-fruit; https://doaj.org/toc/0214-4808; https://doaj.org/toc/2171-861X
Dostęp URL:
https://doaj.org/article/269a1e3f77414d5c810969484667b9bf  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Small-molecule activation of OGG1 increases oxidative DNA damage repair by gaining a new function.
Autorzy:
Michel M; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Benítez-Buelga C; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.; Instituto de Investigaciones Biomédicas Alberto Sols (CSIC/UAM), 28029 Madrid, Spain.
Calvo PA; Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), 28049 Madrid, Spain.
Hanna BMF; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Mortusewicz O; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Masuyer G; Department of Pharmacy and Pharmacology, Centre for Therapeutic Innovation, University of Bath, Bath BA2 7AY, UK.; Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden.
Davies J; Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden.
Wallner O; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Sanjiv K; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Albers JJ; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Castañeda-Zegarra S; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Jemth AS; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Visnes T; Department of Biotechnology and Nanomedicine, SINTEF Industry, N-7465 Trondheim, Norway.
Sastre-Perona A; Experimental Therapies and Novel Biomarkers in Cancer, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Danda AN; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Homan EJ; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Marimuthu K; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Zhenjun Z; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Chi CN; Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
Sarno A; Department of Environment and New Resources, SINTEF Ocean, N-7496 Trondheim, Norway.
Wiita E; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
von Nicolai C; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Komor AJ; Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Department of Biomolecular Chemistry, 07745 Jena, Germany.
Rajagopal V; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Müller S; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Hank EC; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Varga M; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Scaletti ER; Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden.; Department of Experimental Medical Science, Lund University, Lund, Sweden.
Pandey M; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.; Sheffield Cancer Centre, Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2RX, UK.
Karsten S; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Haslene-Hox H; Department of Biotechnology and Nanomedicine, SINTEF Industry, N-7465 Trondheim, Norway.
Loevenich S; Department of Biotechnology and Nanomedicine, SINTEF Industry, N-7465 Trondheim, Norway.
Marttila P; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Rasti A; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Mamonov K; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Ortis F; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Schömberg F; Institute of Organic and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany.
Loseva O; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Stewart J; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
D'Arcy-Evans N; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Koolmeister T; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Henriksson M; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Michel D; Chemical Processes and Pharmaceutical Development, Unit Process Chemistry I, Research Institutes of Sweden - RISE, 151 36 Södertälje, Sweden.
de Ory A; Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 106 91 Stockholm, Sweden.
Acero L; Experimental Therapies and Novel Biomarkers in Cancer, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Calvete O; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
Scobie M; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Hertweck C; Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute, Department of Biomolecular Chemistry, 07745 Jena, Germany.; Institute of Microbiology, Friedrich-Schiller-University Jena, 07743 Jena, Germany.
Vilotijevic I; Institute of Organic and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany.
Kalderén C; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
Osorio A; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Perona R; Instituto de Investigaciones Biomédicas Alberto Sols (CSIC/UAM), 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Stolz A; Institute of Biochemistry II and Buchmann Institute for Molecular Life Science, Goethe University Frankfurt, 60590 Frankfurt, Germany.
Stenmark P; Department of Biochemistry and Biophysics, Stockholm University, 106 91 Stockholm, Sweden.; Department of Experimental Medical Science, Lund University, Lund, Sweden.
Berglund UW; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.
de Vega M; Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM), 28049 Madrid, Spain.
Helleday T; Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, 171 76 Stockholm, Sweden.; Sheffield Cancer Centre, Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2RX, UK.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2022 Jun 24; Vol. 376 (6600), pp. 1471-1476. Date of Electronic Publication: 2022 Jun 23.
Typ publikacji:
Journal Article
MeSH Terms:
DNA Damage*/drug effects
DNA Glycosylases*/chemistry
DNA Glycosylases*/drug effects
DNA Repair*/drug effects
Oxidative Stress*/genetics
Biocatalysis/drug effects ; Enzyme Activation ; Glycine/chemistry ; Humans ; Ligands ; Phenylalanine/chemistry ; Substrate Specificity
Czasopismo naukowe
Tytuł:
A cancer-associated point mutation disables the steric gate of human PrimPol.
Autorzy:
Díaz-Talavera A; Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM) c/Nicolás Cabrera 1, Cantoblanco, 28049, Madrid, Spain.
Calvo PA; Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM) c/Nicolás Cabrera 1, Cantoblanco, 28049, Madrid, Spain.
González-Acosta D; Centro Nacional de Investigaciones Oncológicas (CNIO), c/Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Díaz M; Centro Nacional de Investigaciones Oncológicas (CNIO), c/Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Sastre-Moreno G; Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM) c/Nicolás Cabrera 1, Cantoblanco, 28049, Madrid, Spain.
Blanco-Franco L; Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM) c/Nicolás Cabrera 1, Cantoblanco, 28049, Madrid, Spain.
Guerra S; Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM) c/Nicolás Cabrera 1, Cantoblanco, 28049, Madrid, Spain.
Martínez-Jiménez MI; Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM) c/Nicolás Cabrera 1, Cantoblanco, 28049, Madrid, Spain.
Méndez J; Centro Nacional de Investigaciones Oncológicas (CNIO), c/Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Blanco L; Centro de Biología Molecular 'Severo Ochoa' (CSIC-UAM) c/Nicolás Cabrera 1, Cantoblanco, 28049, Madrid, Spain. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Feb 04; Vol. 9 (1), pp. 1121. Date of Electronic Publication: 2019 Feb 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Point Mutation*
DNA Primase/*chemistry
DNA Primase/*genetics
DNA-Directed DNA Polymerase/*chemistry
DNA-Directed DNA Polymerase/*genetics
Multifunctional Enzymes/*chemistry
Multifunctional Enzymes/*genetics
Neoplasms/*genetics
Animals ; Cell Cycle ; Cell Line ; Computer Simulation ; DNA Primase/metabolism ; DNA-Directed DNA Polymerase/metabolism ; Drug Resistance ; Histidine ; Humans ; Hydroxyurea/pharmacology ; Mice ; Models, Molecular ; Multifunctional Enzymes/metabolism ; Nucleotides/metabolism ; Tyrosine/genetics
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies